PARK7 and Parkinson disease: In chronic cultures of human iPSCs from sporadic and DJ-1 mutant homozygous Parkinson’s disease, the oxidation level increased over 150–180 days and was blocked by metyrosine, an inhibitor of tyrosine hydroxylase [26].